Background: Many studies have reported on trifecta outcomes after radical prostatectomy. There is however paucity of studies that compares the trifecta outcome between screen detected and patients presenting with lower urinary symptoms with localized prostate cancer after radical prostatectomy. This study compares the trifecta outcomes between these two groups after an open retropubic radical prostatectomy. Methodology: This is a retrospective study, on the trifecta outcomes (urinary continence, erectile function, and cancer control) of consecutive patients that had open radical retropubic prostatectomy for localized prostate cancer by a single surgeon. Patients were grouped into screen detected and presentation with lower urinary symptoms or retention of urine. The parameters considered were the age of the patients, the total prostate specific antigen (tPSA) at presentation, the clinical T stage, the Gleason score of prostate biopsies, the risk categories using the D’Amico risk groups and the trifecta outcomes after the procedure. Results: In all, 119 patients met the criteria for inclusion. The median follow up was 63.5 months (range 12 - 156 months). Of these 40.3% of the patients were diagnosed through screening with elevated PSA while 59.7% had presented with symptoms of lower urinary tract obstruction. The mean age for the patients was 60.8 ± 6.5 years, median PSA 12.6 ng/ml (IQR 8.6 - 19.7) and median prostate weight of 50.0 (IQR 40.0 - 60 g). The urinary continence rate after the procedure was 93.3%, erection rate of 81.5%, cancer control rate of 71.4% and trifecta achieved in 57.1%. Comparing the screening and the symptomatic cases, the urinary continence rate was 91.7% vrs 94.3%; erectile function rate was 79.2% vrs 83.1%; cancer control 68.8% vrs 73.2% and trifecta achieved in 58.3% vrs 56.3%. There was no statistically significant difference between the two groups in terms of urinary continence p = 0.564, erection function p = 0.588, cancer control p = 0.595, and achieving trifecta p = 0.829. Conclusion: Patients with localized prostate cancer presenting with lower urinary symptoms compared to screen detected patients have similar outcomes in terms of urinary Continence, erectile function, cancer control and trifecta after open radical retropubic prostatectomy.
References
[1]
Rawla, P. (2019) Epidemiology of Prostate Cancer. World Journal of Oncology, 10, 63-89. https://doi.org/10.14740/wjon1191
[2]
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R.L., Torre, L.A. and Jemal, A. (2018) Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 68, 394-424. https://doi.org/10.3322/caac.21492
[3]
Ferlay, J.E.M., Lam, F., Colombet, M., Mery, L., Pineros, M., Znaor, A., Soerjomataram, I., et al. (2023) Global Cancer Observatory: Cancer Today. International Agency for Research on Cancer, Lyon. https://gco.iarc.fr/today
[4]
Wiredu, E.K. and Armah, H.B. (2006) Cancer Mortality Patterns in Ghana: A 10-Year Review of Autopsies and Hospital Mortality. BMC Public Health, 6, Article No. 159. https://doi.org/10.1186/1471-2458-6-159
[5]
Yeboah, E.D., Hsing, A.W., Mante, S., Mensah, J.E., Kyei, M.Y., Yarney, J., Vanderpuye, V., Beecham, K., Tettey, Y., Biritwum, R.B., Adjei, A.A., Gyasi, R., Asante, K., Ampadu, K.N., Klufio, G.O., Gepi-Attee, S., Owoo, C., Kwami, D., Ahiaku, Pandra, R. and Cook, M.B. (2016) Management of Prostate Cancer in Accra, Ghana. Journal of West African College of Surgeons, 6, 31-65.
[6]
Moyer, V.A. (2012) Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement. Annals of Internal Medicine, 157, 120-134. https://doi.org/10.7326/0003-4819-157-2-201207170-00459
[7]
Bill-Axelson, A., Holmberg, L., Garmo, H., et al. (2018) Radical Prostatectomy or Watchful Waiting in Prostate Cancer—29-Year Follow-up. The New England Journal of Medicine, 379, 2319-2329. https://doi.org/10.1056/NEJMoa1807801
[8]
Panigrahi, G.K., Praharaj, P.P., Kittaka, H., Mridha, A.R., Black, O.M., Singh, R., Mercer, R., et al. (2019) Exosome Proteomic Analyses Identify Inflammatory Phenotype and Novel Biomarkers in African American Prostate Cancer Patients. Cancer Medicine, 8, 1110-1123. https://doi.org/10.1002/cam4.1885
[9]
Necku, J.G., Anaba, E.A. and Abuosi, A.A. (2019) Prostate Cancer Awareness and Attitude toward Early Detection among Male Soldiers in Ghana: A Cross-Sectional Study. African Journal of Urology, 25, Article No. 5. https://doi.org/10.1186/s12301-019-0004-3
[10]
Lee, S.D., Akbal, C. and Jung, C. (2006) Intravesical Pressure Induces Hyperplasia and Hypertrophy of Human Bladder Smooth Muscle Cells Mediated by Muscarinic Receptors. Journal of Pediatric Urology, 2, 271-276. https://doi.org/10.1016/j.jpurol.2005.11.015
[11]
Deveaud, C.M., Macarak, E.J., Kucich, U., et al. (1998) Molecular Analysis of Collagens in Bladder Fibrosis. The Journal of Urology, 160, 1518-1527. https://doi.org/10.1016/S0022-5347(01)62606-5
[12]
Komninos, C. and Mitsogiannis, I. (2014) Obstruction-Induced Alterations within the Urinary Bladder and Their Role in the Pathophysiology of Lower Urinary Tract Symptomatology. Canadian Urological Association Journal, 8, E524-E530. https://doi.org/10.5489/cuaj.1636
[13]
Sanda, M.G., Cadeddu, J.A., Kirkby, E., et al. (2018) Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline. Part I: Risk Stratification, Shared Decision Making, and Care Options. The Journal of Urology, 199, 683-690. https://doi.org/10.1016/j.juro.2017.11.095
[14]
Eastham, J.A., Auffenberg, G.B., Barocas, D.A., Roger Chou, R., Crispino, T., Davis, J.W., Eggener, S., Horwitz, E.M., Kane, C.J., Kirkby, E., Lin, D.W., McBride, S., Morgans, A.K., Pierorazio, P.M., Rodrigues, G., Wong, W.W. and Boorjian, S.A. (2022) Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, Part I: Introduction, Risk Assessment, Staging, and Risk-Based Management. The Journal of Urology, 208, 10-18. https://doi.org/10.1097/JU.0000000000002757
[15]
Entebi, E., Eldefrawy, A., Katkoori, D., Soloway, C.T., Manoharan, M. and Soloway, M.S. (2011) Oncological and Functional Outcomes following Open Radical Prostatectomy: How Patients May Achieve the Trifecta. International Braz J Urol, 37, 320-327. https://doi.org/10.1590/S1677-55382011000300005
[16]
Yaxley, J.W., Coughlin, G.D., Chambers, S.K., et al. (2016) Robot-Assisted Laparoscopic Prostatectomy versus Open Radical Retropubic Prostatectomy: Early Outcomes from a Randomised Controlled Phase 3 Study. The Lancet, 388, 1057-1066. https://doi.org/10.1016/S0140-6736(16)30592-X
[17]
Kyei, M.Y., Mensah, J.E., Gepi-Attee, S., Kwami, D., Ampadu, K., Asante, E., Klufio, G.O. and Yeboah, E.D. (2013) Outcomes after Radical Prostatectomy in Ghana: A Surgeons Early Experience. International Scholarly Research Notic, 2013, Article ID: 832496. https://doi.org/10.1155/2013/832496
[18]
Bianco Jr., F.J., Scardino, P.T. and Eastham, J.A. (2005) Radical Prostatectomy: Long-Term Cancer Control and Recovery of Sexual and Urinary Function (“Trifecta”). Urology, 66, 83-94. https://doi.org/10.1016/j.urology.2005.06.116
[19]
Slova, D. and Lepor, H. (2007) The Short-Term and Long-Term Effects of Radical Prostatectomy on Lower Urinary Tract Symptoms. The Journal of Urology, 178, 2397-2400. https://doi.org/10.1016/j.juro.2007.08.004
[20]
Namiki, S., Saito, S., Ishidoya, S., et al. (2005) Adverse Effect of Radical Prostatectomy on Nocturia and Voiding Frequency Symptoms. Urology, 66, 147-151. https://doi.org/10.1016/j.urology.2005.01.020
[21]
D’Amico, A.V., Whittington, R., Malkowicz, S.B., Schultz, D., Blank, K., Broderick, G.A., Tomaszewski, J.E., Renshaw, A.A., Kaplan, I., Beard, C.J. and Wein, A. (1998) Biochemical Outcome after Radical Prostatectomy, External Beam Radiation Therapy, or Interstitial Radiation Therapy for Clinically Localized Prostate Cancer. JAMA, 280, 969-974. https://doi.org/10.1001/jama.280.11.969
[22]
Kyei, M.Y., Adusei, B., Klufio, G.O., Mensah, J.E., Gepi-Attee, S. and Asante, E. (2020) Treatment of Localized Prostate Cancer and Use of Nomograms among Urologists in the West Africa Sub-Region. The Pan African Medical Journal, 36, Article 251. https://doi.org/10.11604/pamj.2020.36.251.21419
[23]
Cachoeira, E.T., de Oliveira Paludo, A., Knijnik, P.G., et al. (2023) Pentafecta Outcomes of Robotic Laparoscopically Assisted Radical Prostatectomy during the Initial Experience in a University Hospital. African Journal of Urology, 29, Article No. 7. https://doi.org/10.1186/s12301-023-00338-6
[24]
Porter, C.R., Kodama, K., Gibbons, R.P., et al. (2006) 25-Year Prostate Cancer Control and Survival Outcomes: A 40-Year Radical Prostatectomy Single Institution Series. The Journal of Urology, 176, 569-574. https://doi.org/10.1016/j.juro.2006.03.094
[25]
Dmochowski, R.R. (2009) Overactive Bladder in Males. Therapeutic Advances in Urology, 1, 209-221. https://doi.org/10.1177/1756287209350383
[26]
Klevmark, B. (1974) Motility of the Urinary Bladder in Cats during Filling at Physiological Rates: I. Intravesical Pressure Patterns Studies by a New Method of Cystometry. Acta Physiologica Scandinavica, 90, 565-577. https://doi.org/10.1111/j.1748-1716.1974.tb05621.x
